- Apotex Health (TSX:APTX) began trading today on the TSX, marking the largest life sciences IPO by total proceeds in the exchange’s history.
- Apotex is the largest Canadian-based pharmaceutical company.
- Apotex stock is up by 12.50 per cent trading at C$27 as of 12:48 pm ET.
Apotex Health (TSX:APTX), the largest Canadian-based pharmaceutical company, began trading today on the TSX, marking the largest life sciences IPO by total proceeds in the exchange’s history.
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
Apotex, based in Toronto, with offices in Mexico, India and the United States, provides access to more than 670 affordable medicines and healthcare products to millions of people across the world.
According to Tuesday’s news release, the company is expected to raise C$1.3 billion, making it one of the largest IPOs in TSX history, joining 110 life sciences companies listed on both the TSX and TSXV with a combined market capitalization of C$26 billion.
Jeff Watson, President and CEO of Apotex, will join John McKenzie, CEO of TMX Group, to open trading on Thursday, June 11, to celebrate the milestone listing.
Leadership commentary
“We are extremely proud to welcome Apotex, a Canadian company competing on the global stage, to the Toronto Stock Exchange. Its debut is a testament to the strength of the Canadian capital markets and shows the potential of the life sciences sector to the world,” Loui Anastasopoulos, CEO of the Toronto Stock Exchange, said in Wednesday’s news release. “On behalf of all of us at TSX, congratulations to the entire Apotex team on this huge achievement.”
“Today marks an important milestone in Apotex’s journey as we begin trading on the Toronto Stock Exchange,” Watson added. “This listing reflects the strength of our global business and the dedication of our teams who are committed to improving access to affordable, high-quality medicines for patients around the world. We are proud to be the leading Canadian-based health company, and excited for the opportunities ahead as we continue to invest in innovation, expand our reach and deliver long-term value for patients and shareholders alike.”
About Apotex Health
Apotex is the largest Canadian-based pharmaceutical company.
Apotex Health stock (TSX:APTX) is up by 12.50 per cent trading at C$27 as of 12:48 pm ET.
Join the discussion: Find out what investors are saying about this Canadian healthcare stock on the Apotex Health Corp. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.